This journal focuses on the application of genomic and molecular diagnostics to personalize medicine. It examines the role of genetic variations, microRNAs, and other biomarkers in disease susceptibility, diagnosis, prognosis, and treatment response across various conditions including neurological disorders, cancers, and fibrotic diseases. The journal also explores the integration of multi-omics data, artificial intelligence, and real-world evidence in clinical practice and regulatory decision-making.
AI-summarised from recent articles · verify on the publisher page
⚡ Speed vs Prestige
How does this journal balance review speed with impact level?
BRCA gene mutations in cancerPharmacogenetics and Drug MetabolismGenomics and Rare DiseasesCancer Genomics and DiagnosticsEthics in Clinical ResearchHealth Systems, Economic Evaluations, Quality of LifeNutrition, Genetics, and DiseaseBioinformatics and Genomic NetworksComputational Drug Discovery MethodsBiomedical Ethics and Regulation